{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:22:01Z","timestamp":1790896921890,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunocompromised patients show prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal swabs. We report a case of prolonged persistence of viable SARS-CoV-2 associated with clinical relapses of coronavirus disease 2019 (COVID-19) in a patient with mantle cell lymphoma who underwent treatment with rituximab, bendamustine, cytarabine with consequent lymphopenia and hypogammaglobulinemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Nasopharyngeal swabs and blood samples were tested for SARS-CoV-2 by real-time polymerase chain reaction (RT-PCR). On 5 positive nasopharyngeal swabs, we performed viral culture and next-generation sequencing. We analyzed the patient\u2019s adaptive and innate immunity to characterize T- and NK-cell subsets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SARS-CoV-2 RT-PCR on nasopharyngeal swabs samples remained positive for 268 days. All 5 performed viral cultures were positive, and genomic analysis confirmed a persistent infection with the same strain. Viremia resulted positive in 3 out of 4 COVID-19 clinical relapses and cleared each time after remdesivir treatment. The T- and NK-cell dynamic was different in aviremic and viremic samples, and no SARS-CoV-2-specific antibodies were detected throughout the disease course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In our patient, SARS-CoV-2 persisted with proven infectivity for &amp;gt;8 months. Viremia was associated with COVID-19 relapses, and remdesivir treatment was effective in viremia clearance and symptom remission, although it was unable to clear the virus from the upper respiratory airways. During the viremic phase, we observed a low frequency of terminal effector CD8+ T lymphocytes in peripheral blood; these are probably recruited in inflammatory tissue for viral eradication. In addition, we found a high level of NK-cell repertoire perturbation with relevant involvement during SARS-CoV-2 viremia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofab217","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T18:52:17Z","timestamp":1619635937000},"source":"Crossref","is-referenced-by-count":75,"title":["The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient\u2014A Case Study"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1761-436X","authenticated-orcid":false,"given":"Chiara","family":"Sepulcri","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-5812","authenticated-orcid":false,"given":"Chiara","family":"Dentone","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5535-4602","authenticated-orcid":false,"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"},{"name":"Infectious Diseases Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3456-1899","authenticated-orcid":false,"given":"Bianca","family":"Bruzzone","sequence":"additional","affiliation":[{"name":"Hygiene Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3174-5721","authenticated-orcid":false,"given":"Alessia","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9532-6473","authenticated-orcid":false,"given":"Daniela","family":"Fenoglio","sequence":"additional","affiliation":[{"name":"Center of Excellence for Biomedical Research, Cytofluorimetry Unit, University of Genoa, Genoa, Italy"},{"name":"Biotherapy Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6861-1727","authenticated-orcid":false,"given":"Federica","family":"Bozzano","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1653-1917","authenticated-orcid":false,"given":"Annalisa","family":"Bergna","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8476-8241","authenticated-orcid":false,"given":"Alessia","family":"Parodi","sequence":"additional","affiliation":[{"name":"Biotherapy Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Altosole","sequence":"additional","affiliation":[{"name":"Center of Excellence for Biomedical Research, Cytofluorimetry Unit, University of Genoa, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2973-5719","authenticated-orcid":false,"given":"Emanuele","family":"Delfino","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bartalucci","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2433-9610","authenticated-orcid":false,"given":"Andrea","family":"Orsi","sequence":"additional","affiliation":[{"name":"Hygiene Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"},{"name":"Hygiene Unit, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1436-5089","authenticated-orcid":false,"given":"Antonio","family":"Di Biagio","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"},{"name":"Infectious Diseases Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1886-2915","authenticated-orcid":false,"given":"Gianguglielmo","family":"Zehender","sequence":"additional","affiliation":[{"name":"Hygiene Unit, Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8954-6752","authenticated-orcid":false,"given":"Filippo","family":"Ballerini","sequence":"additional","affiliation":[{"name":"Hematology Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-3341","authenticated-orcid":false,"given":"Stefano","family":"Bonora","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Ospedale Amedeo di Savoia, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA"},{"name":"Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9070-8878","authenticated-orcid":false,"given":"Raffaele","family":"De Palma","sequence":"additional","affiliation":[{"name":"Biotherapy Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"},{"name":"Immunology Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6602-2470","authenticated-orcid":false,"given":"Guido","family":"Silvestri","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA"},{"name":"Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory Vaccine Center, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5782-333X","authenticated-orcid":false,"given":"Andrea","family":"De Maria","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"},{"name":"Infectious Diseases Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-9740","authenticated-orcid":false,"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"},{"name":"Infectious Diseases Unit, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"2021111802400235800_CIT0001","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","article-title":"SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis","volume":"2","author":"Cevik","year":"2021","journal-title":"Lancet Microbe"},{"key":"2021111802400235800_CIT0002","doi-asserted-by":"crossref","first-page":"e039856","DOI":"10.1136\/bmjopen-2020-039856","article-title":"Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases","volume":"10","author":"Byrne","year":"2020","journal-title":"BMJ Open"},{"key":"2021111802400235800_CIT0003","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"2021111802400235800_CIT0004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiaa666","article-title":"Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient","volume":"223","author":"Baang","year":"2021","journal-title":"J Infect Dis"},{"key":"2021111802400235800_CIT0005","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"2021111802400235800_CIT0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2020.12.001","article-title":"Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient","author":"Nakajima","year":"2021;","journal-title":"J Infect Chemother"},{"key":"2021111802400235800_CIT0007","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"key":"2021111802400235800_CIT0008","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"2021111802400235800_CIT0009","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat Med"},{"key":"2021111802400235800_CIT0010","article-title":"Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples","author":"Liotti","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021111802400235800_CIT0011","author":"Global Initiative on Sharing All Influenza Data (GISAID)","year":"2020"},{"key":"2021111802400235800_CIT0012","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","article-title":"Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data","volume":"28","author":"Kearse","year":"2012","journal-title":"Bioinformatics"},{"key":"2021111802400235800_CIT0013"},{"key":"2021111802400235800_CIT0014"},{"key":"2021111802400235800_CIT0015","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"2021111802400235800_CIT0016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00251-019-01137-6","article-title":"The Immune Epitope Database and Analysis Resource Program 2003-2018: reflections and outlook","volume":"72","author":"Martini","year":"2020","journal-title":"Immunogenetics"},{"key":"2021111802400235800_CIT0017"},{"key":"2021111802400235800_CIT0018","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/biomedicines8100376","article-title":"The impacts of antivirals on the coronavirus genome structure and subsequent pathogenicity, virus fitness and antiviral design","volume":"8","author":"Lin","year":"2020","journal-title":"Biomedicines"},{"key":"2021111802400235800_CIT0019","doi-asserted-by":"crossref","article-title":"Rational design of the remdesivir binding site in the RNA-dependent RNA polymerase of SARS-CoV-2: implications for potential resistance","author":"Padhi","DOI":"10.1101\/2020.06.27.174896"},{"key":"2021111802400235800_CIT0020","doi-asserted-by":"crossref","first-page":"104793","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites","volume":"178","author":"Shannon","year":"2020","journal-title":"Antiviral Res"},{"key":"2021111802400235800_CIT0021","doi-asserted-by":"crossref","first-page":"e00221","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"key":"2021111802400235800_CIT0022","doi-asserted-by":"crossref","first-page":"26946","DOI":"10.1073\/pnas.2012294117","article-title":"Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases","volume":"117","author":"Lo","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021111802400235800_CIT0023","article-title":"Remdesivir failure with SARS-CoV-2 RNA-dependent RNA-polymerase mutation in a B-cell immunodeficient patient with protracted Covid-19","author":"Martinot","journal-title":"Clin Infect Dis"},{"key":"2021111802400235800_CIT0024","doi-asserted-by":"crossref","first-page":"16156","DOI":"10.1074\/jbc.AC120.015720","article-title":"Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action","volume":"295","author":"Tchesnokov","year":"2020","journal-title":"J Biol Chem"},{"key":"2021111802400235800_CIT0025","doi-asserted-by":"crossref","first-page":"100721","DOI":"10.1016\/j.drup.2020.100721","article-title":"Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses","volume":"53","author":"Artese","year":"2020","journal-title":"Drug Resist Updat"},{"key":"2021111802400235800_CIT0026","article-title":"SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study","author":"Hagman","year":"","journal-title":"Clin Infect Dis"},{"key":"2021111802400235800_CIT0027","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s13054-020-03398-0","article-title":"Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19","volume":"24","author":"Bermejo-Martin","year":"2020","journal-title":"Crit Care"},{"key":"2021111802400235800_CIT0028","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N Engl J Med"},{"key":"2021111802400235800_CIT0029","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/infdis\/jiaa446","article-title":"Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy","volume":"222","author":"Helleberg","year":"2020","journal-title":"J Infect Dis"},{"key":"2021111802400235800_CIT0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijid.2020.12.050","article-title":"Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir","volume":"104","author":"Camprub\u00ed","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2021111802400235800_CIT0031","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood.2020008423","article-title":"Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19","volume":"136","author":"Hueso","year":"2020","journal-title":"Blood"},{"key":"2021111802400235800_CIT0032","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial [published correction appears in JAMA 2020; 324:519]","volume":"324","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"2021111802400235800_CIT0033","doi-asserted-by":"crossref","first-page":"m3939","DOI":"10.1136\/bmj.m3939","article-title":"Convalescent plasma in the management of moderate COVID-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) [published correction appears in BMJ 2020; 371:m4232]","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"2021111802400235800_CIT0034","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"2021111802400235800_CIT0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat Med"},{"key":"2021111802400235800_CIT0036","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/eji.200425251","article-title":"Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients","volume":"34","author":"Fogli","year":"2004","journal-title":"Eur J Immunol"},{"key":"2021111802400235800_CIT0037","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.1200458","article-title":"Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation","volume":"189","author":"Lichtfuss","year":"2012","journal-title":"J Immunol"},{"key":"2021111802400235800_CIT0038","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1073\/pnas.1302090110","article-title":"Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation","volume":"110","author":"Marras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021111802400235800_CIT0039","doi-asserted-by":"crossref","first-page":"e1009448","DOI":"10.1371\/journal.ppat.1009448","article-title":"Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity","volume":"17","author":"Bozzano","year":"2021","journal-title":"PLoS Pathog"},{"key":"2021111802400235800_CIT0040","doi-asserted-by":"crossref","first-page":"100549","DOI":"10.1016\/j.eclinm.2020.100549","article-title":"Determinants of outcome in Covid-19 hospitalized patients with lymphoma: a retrospective multicentric cohort study","volume":"27","author":"Lamure","year":"2020","journal-title":"EClinicalMedicine"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofab217\/37532667\/ofab217.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/8\/11\/ofab217\/41147140\/ofab217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/8\/11\/ofab217\/41147140\/ofab217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T21:55:08Z","timestamp":1637186108000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofab217\/6257145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofab217","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.23.21249554","asserted-by":"object"}]},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,4,28]]},"article-number":"ofab217"}}